Barchart7d agobearish
Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.BetterHelp remains Teladoc’s biggest headache as customers shift toward insurance-covered therapy and provider capacity struggles to keep up.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
328last 24h
2141last 7d
379● bullish (7d)
188● bearish (7d)
204publishers
The Wall Street Journal13d agobearish
🔎 Under the Radar: Teladoc Shares Tumble on Therapist ShortageShares of Teladoc Health fell more than 25% Thursday after the telehealth company missed second-quarter revenue expectations and cut its full-year sales forecast. The pain is concentrated in BetterHelp, Teladoc's therapy and psychiatry platform, where revenue fell 12% to $212.6 million. Teladoc has pushed BetterHelp users toward insurance-covered therapy instead of cash-pay sessions.
MT Newswires13d agobearish
Teladoc Health Q2 Loss Widens, Revenue Falls; 2026 Guidance UpdatedTeladoc Health (TDOC) reported a Q2 loss late Wednesday of $0.21 per diluted share, wider than a los
24/7 Wall St.86d agobearish
Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own InsteadHims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector’s short history, and bargain hunters are circling the wreckage. But here’s what you should actually be watching. The Q1 2026 release on May 11, 2026 was a fracture. EPS came in ... Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead